
Last updated: 3 months ago
SuperCom Ltd. 6-K Report: New Warrant Agreement & Share Issuance Details
Explore SuperCom Ltd.'s February 2025 6-K report detailing new warrants, issuance terms, and SEC compliance.
Explore SuperCom Ltd.'s February 2025 6-K report detailing new warrants, issuance terms, and SEC compliance.
Explore Silexion Therapeutics Corp's latest 8-K report detailing stock and warrant information, potential capital-raising strategies, and market implications for investors.